| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $25.7M | -55.1% |
| SG&A Expense | $10.9M | -15.4% |
| Operating Income | -$41.1M | +41.4% |
| Pre-tax Income | $10.1M | +115.0% |
| Income Tax | $5.3M | +798.3% |
| Net Income | $4.8M | +107.1% |
| EPS (Basic) | $0.07 | +103.9% |
| EPS (Diluted) | $0.07 | +103.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | -70.3% |
| Current Assets | $162.1M | +237.4% |
| Total Assets | $163.2M | +232.2% |
| Current Liabilities | $4.6M | -67.6% |
| Total Liabilities | $9.7M | -31.3% |
| Stockholders' Equity | $153.5M | +338.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.9M | +27.2% |
| Investing Cash Flow | -$97.0M | — |
| Financing Cash Flow | $107.6M | +189.5% |